Acer Therapeutics Inc. Quarterly Other Liabilities, Noncurrent in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Acer Therapeutics Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q1 2019 to Q3 2023.
  • Acer Therapeutics Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2023 was $76.7K, a 54.2% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $76.7K -$90.6K -54.2% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $101K -$65.3K -39.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $124K -$70.2K -36.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $146K -$63.8K -30.5% Dec 31, 2022 10-Q 2023-11-20
Q3 2022 $167K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $166K Jun 30, 2022 10-Q/A 2022-11-14
Q1 2022 $194K -$4.67M -96% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $209K -$34.3K -14.1% Dec 31, 2021 10-K 2023-03-27
Q1 2021 $4.86M +$4.59M +1695% Mar 31, 2021 10-Q/A 2021-11-19
Q4 2020 $244K -$82.5K -25.3% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $374K +$110K +41.5% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $525K +$214K +68.6% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $271K +$25.8K +10.5% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $326K Dec 31, 2019 10-K 2021-03-01
Q3 2019 $264K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $312K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $245K Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.